Editorial Board

Editors-In-Chief

  • Charles Nemeroff, MD, PhD, The University of Texas at Austin, Department of Psychiatry and Behavioral Sciences, Austin, United States of America
  • Giampaolo Robert Perna, MD, PhD, Humanitas University,, Department of Biological Sciences, Milan, Italy

Editorial Board

  • Alessandro Bertolino, MD, University of Bari, Department of Mathematics, Bari, Italy, Schizophrenia,  Functional imaging,  Genetics,  Functional genetics,  Antipsychotics,  Cognition,  Personalized medicine
  • Elisabeth B. Binder, MD, PhD, Max-Planck-Institute for Psychiatry, München, Germany, Genetics,  Epigenetics,  Gene x Environment interactions,  Stress
  • Kathleen T. Brady, MD, PhD, MUSC Health Institute of Psychiatry, Charleston, South Carolina, United States of America, Substance use disorders,  Post traumatic stress disorder,  Comorbidity,  Translational research
  • Daniela Caldirola, PhD, San Benedetto Menni Hospital, Albese Con Cassano, Italy, Psychophysiology of panic and anxiety disorders,  Psychopharmacology,  Affective disorders,  Mental-medical disorder connections
  • Edward W. Craighead, PhD, ABPP, Emory University School of Medicine, Atlanta, Georgia Georgia, United States of America, Depression,  Bipolar Disorders,  Cognitive Behavior Therapy,  Behavior Therapy,  Personality Disorders
  • Mark Frye, MD, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States of America, Bipolar Disorder,  Treatment resistant depression,  pharmacogenomics,  novel treatments drug development
  • Glen O. Gabbard, MD, Baylor College of Medicine, Houston, Texas, United States of America
  • Wayne K. Goodman, MD, Baylor College of Medicine, Houston, Texas, United States of America, Obsessive-compulsive disorder (OCD),  deep brain stimulation (DBS) 
  • Salvador M. Guinjoan, MD, Laureate Institute for Brain Research, Tulsa, Oklahoma, United States of America, Depression,  Brain Imaging,  Emotion,  Cognition,  Autonomic Nervous System,  Neuromodulation
  • Philip D. Harvey, PhD, University of Miami School of Medicine, Miami, Florida, United States of America, Serious mental illness,  Cognition,  Everyday functioning,  Technology and Mental illness
  • Christine Heim, PhD, Charite University Hospital Berlin, Berlin, Germany, Psychoneuroendocrinology,  Stress,  Cognition,  Early Adversity,  Neurodevelopment
  • Paul E. Holtzheimer, MD, Dartmouth Geisel Medical School Community and Family Medicine, Lebanon, New Hempshire, United States of America, Mood disorders,  PTSD,  Brain stimulation,  Brain imaging,  Treatment-resistant depression
  • Rene Hurlemann, MD, Carl von Ossietzky University of Oldenburg, Faculty VI Medicine and Health Sciences, Oldenburg, Germany, Personalized neuromodulation via hormonal,  Pharmacological and brain stimulation methods,  Digital social phenotyping and therapeutics,  Neuroimaging-based predictive biotyping
  • Ned H. Kalin, MD, PhD, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, Depression,  Anxiety,  Development,  Neurobiological,  Neuroscience Translational Research
  • James L. Kennedy, MD, FRSC, University of Toronto, Toronto, Ontario, Canada, Pharmacogenomics,  Psychiatry,  Epigenetics,  Genetic risk,  Clinical trials
  • Mario Maj, MD, Università di Napoli, Largo Madonna delle Grazie, Clinica Psichiatrica, Naples, Italy, Clinical characterization and personalization of management of depression,  Clinical characterization and personalization of management of primary psychoses,  Categorical,  dimensional and prototypical approaches to diagnosis in psychiatry
  • Gin Malhi, MD, The University of Sydney, Sydney, New South Wales, Australia
  • Helen Mayberg, MD, Emory University School of Medicine,, Department of Psychiatry, Atlanta, Georgia Georgia, United States of America, Neuroimaging,  Invasive neuromodulation,  Depression
  • William McDonald, MD, Emory Healthcare, Atlanta, Georgia, United States of America, Mood and Anxiety disorders,  ECT,  TMS and Ketamine
  • Antonio Egidio Nardi, MD, PhD, Federal University of Rio de Janeiro, RIO DE JANEIRO, Brazil, Anxiety,  Panic disorder,  Social phobia,  Psychopharmacology,  Depression,  Antidepressants,  Psychopathology,  Bipolar disorder,  Benzodiazepines,  Neuroscience
  • Carmine M. Pariante, MD, PhD, King's College London Institute of Psychiatry Psychology and Neuroscience The Maurice Wohl Clinical Neuroscience Institute, London, United Kingdom, Depression,  Affective disorders,  Stress,  Inflammation,  Antidepressants
  • Kerry Ressler, MD, PhD, McLean Hospital, Belmont, Massachusetts, United States of America, PTSD, Genomics, Amygdala, Fear, Stress, Anxiety
  • Alan F. Schatzberg, MD, Stanford University School of Medicine, Stanford, California, United States of America, Antidepressants,  Biomarkers,  Glucocorticoids,  Pharmacogenetics,  Brain stimulation
  • Thomas E. Schlaepfer, PhD, University of Bonn, Bonn, Germany, Psychiatry and Psychology
  • Steven J. Siegel, MD, PhD, University of Southern California, Department of Psychiatry and Behavioral Sciences, Los Angeles, California, United States of America, Schizophrenia,  Psychosis,  Psychopharmacology,  NMDA,  Glutamate
  • Dan Stein, FRCPC, PhD, DPhil, University of Cape Town Division of Emergency Medicine, Cape Town, South Africa, Anxiety and related disorders, Psychiatry in Africa, Philosophy of psychiatry
  • Stephen Strakowski, MD, The University of Texas at Austin Dell Medical School, Austin, Texas, United States of America, Bipolar disorder,  neuroimaging,  treatment trials,  race bias in psychiatry
  • Paul Summergrad, MD, Tufts University School of Medicine, Boston, Massachusettes, United States of America, Mood disorders,  Treatment-resistant depression,  Medical Psychiatric Illness,  Health System Design and Economics,  Psychedelics and Mindfulness
  • Madhukar Trivedi, MD, The University of Texas Southwestern Medical School Center for Depression Research and Clinical Care, Dallas, Texas, United States of America, Brain and FLuid Based Biomarker Development and Validation for Depression,   Precision Medicine,   Treatment Resistant Depression,   Measurement Based Care for Psychiatry
  • Claes Wahlestedt, MD, PhD, University of Miami, Department of Psychiatry and Behavioral Sciences, Miami, Florida, United States of America, Drug discovery,  Personalized medicine,  Clinical trials,  Biomarkers,  Genomics,  Genetics,  Bioinformatics
  • Daniel R. Weinberger, MD, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Behavior genetics,  Schizophrenia,  Bipolar disorder,  Neuroscience
  • Zhexing Wen, PdD, Emory University, Department of Psychiatry and Behavioral Sciences, Atlanta, Georgia, United States of America, Induced pluripotent stem cells,  Neurogenomics,  Neural development,  Synaptic transmission,  Neuropsychiatric disorders
  • Leanne M. Williams, PhD, Stanford University, Department of Psychiatry and Behavioral Sciences, Palo Alto, California, United States of America, Depression,  Functional neuroimaging,  Biomarker,  Precision medicine,  Treatment